Christopher George Mueller

Christopher George Mueller

Auto-generated profile, based on publicly available information

Christopher George Mueller

Laboratory CNRS I2CT/UPR3572 Immunology, Immunopathology and Therapeutic Chemistry, Strasbourg Drug Discovery and Development Institute (IMS), Institut de Biologie Moleculaire et Cellulaire, Strasbourg, France

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 1994 in Genes & Development
Verified
Journal Article
Closed access
PDF file
DAD T Auble
D T Auble
KHK E Hansen
K E Hansen
CMC G Mueller
C G Mueller
WLW S Lane
W S Lane
JTJ Thorner
J Thorner
SHS Hahn
S Hahn
Basal transcription of many genes in yeast is repressed by Mot1, an essential protein which is a member of the Snf2/Swi2 family of conserved nuclear factors. ADI is an ATP-dependent inhibitor of TATA-binding protein (TBP) binding to DNA that inhibits transcription in vitro. Here we demonstrate that ADI is encoded by the MOT1 gene. Mutation of MOT1 abolishes ADI activity and derepresses basal transcription in vitro and in vivo. Recombinant Mot1 removes TBP from DNA and Mot1 contains an ATPase activity which is essential for its function. Genetic interactions between Mot1 and TBP indicate that their functions are interlinked in vivo. These results provide a general model for understanding the mechanism of action of a large family of nuclear factors involved in processes such as transcription and DNA repair.

1 July 2017 in Immunity
Verified
Journal Article
Closed access
LOLucas Onder
Lucas Onder
UMUrs Mörbe
Urs Mörbe
NPNatalia Pikor
Natalia Pikor
MNMario Novkovic
Mario Novkovic
HCHung-Wei Cheng
Hung-Wei Cheng
BLBurkhard Ludewig
Burkhard Ludewig

1 June 2019 in Immunity
Verified
Journal Article
Closed access
ACAbdouramane Camara
Abdouramane Camara
OCOlga G. Cordeiro
Olga G. Cordeiro
FAFarouk Alloush
Farouk Alloush
JSJanina Sponsel
Janina Sponsel
MCMélanie Chypre
Mélanie Chypre
CMChristopher G. Mueller
Christopher G. Mueller

25 July 2011 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
MCMihai Ciobanu
Mihai Ciobanu
KHKuo-Ting Huang
Kuo-Ting Huang
JDJean-Pierre Daguer
Jean-Pierre Daguer
SBSofia Barluenga
Sofia Barluenga
OCOlivier Chaloin
Olivier Chaloin
NWNicolas Winssinger
Nicolas Winssinger
We report the synthesis of a nucleic acid-encoded carbohydrate library, its combinatorial self-assembly into 37 485 pairs and a screen against DC-SIGN leading to the identification of consensus ligand motifs. A prototypical example from the selected pairs was shown to have enhanced binding. A dendrimer incorporating the selected motifs inhibited gp120's binding to dendritic cells with higher efficiency than mannan.

1 August 2016 in Cytokine
Verified
Journal Article
Closed access
DDDamien Dietrich
Damien Dietrich
PMPraxedis Martin
Praxedis Martin
VFVincent Flacher
Vincent Flacher
YSYu Sun
Yu Sun
DJDavid Jarrossay
David Jarrossay
CGCem Gabay
Cem Gabay

1 January 2012 in Frontiers in Immunology
Verified
Journal Article
Open access
CMChristopher G. Mueller
Christopher G. Mueller
EHEstelle Hess
Estelle Hess
The tumor necrosis factor superfamily (TNFSF) members play pivotal roles in embryonic development of lymphoid tissue and their homeostasis. RANKL (Receptor activator of NF-κB ligand, also called TRANCE, TNFSF11) is recognized as an important player in bone homeostasis and lymphoid tissue formation. In its absence bone mass control is deregulated and lymph nodes fail to develop. While its function in bone is well described, there is still little functional insight into the action of RANKL in lymphoid tissue development and homeostasis. Here we provide an overview of the known functions of RANKL, its signaling receptor RANK and its decoy receptor OPG from the perspective of lymphoid tissue development and immune activation in the mouse. Expressed by the hematopoietic lymphoid tissue inducing (LTi) cells and the mesenchymal lymphoid tissue organizer (LTo) cells, RANKL was shown to stimulate Lymphotoxin (LT) expression and to be implicated in LTi cell accumulation. Our recent finding that RANKL also triggers proliferation of adult lymph node stroma suggests that RANKL may furthermore directly activate LTo cells. Beyond bone, the RANKL-RANK-OPG triad plays important roles in immunobiology that are waiting to be unraveled.